Empagliflozin improves symptoms, reduces hospitalization in HF patients: EMPEROR-preserved Trial Dr.Niharika Harsha B30 Jun 2022 7:30 PM ISTResearchers have found in EMPEROR-preserved trial that in heart failure patients symptoms were improved, primary outcomes were reduced and...
Empagliflozin effectively regulates Serum potassium in Heart Failure, study Dr. Hiral patel24 Jun 2022 7:30 PM ISTFrance: Empagliflozin (anti-diabetic medication) reduced the incidence of hyperkalemia without a substantial increase in hypokalemia in patients with...
Empagliflozin may decrease risk of kidney stones in people with diabetes Dr. Kamal Kant Kohli15 Jun 2022 9:15 AM ISTThe diabetes drug empagliflozin may decrease the risk of kidney stones in patients with type 2 diabetes, according to a new study presented Sunday,...
Empagliflozin may decrease risk of kidney stones in diabetics Dr. Nandita Mohan14 Jun 2022 10:00 AM ISTWe all know that Empagliflozin is the drug used along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in...
All SGLT-2 inhibitors found promising for diabetes management in Indian settings: JAPI Medha Baranwal11 Jun 2022 11:30 AM ISTMaharashtra: SGLT2 Inhibitors could be considered as an add-on to all antidiabetic agents currently used for diabetes management in the Indian...
Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
Journal Club - Empagliflozin to Improve Heart Failure Symptoms Dr. Nandita Mohan5 May 2022 4:30 PM ISTPatients hospitalized for acute heart failure (AHF) experience poor health status, including high burden of symptoms and physical limitations, and...
Empagliflozin rapidly improves symptoms and QoL in Hospitalised AHF Patients: EMPULSE Trial Medha Baranwal18 April 2022 9:45 AM ISTUSA: Treatment with empagliflozin in patients hospitalized for acute heart failure (AHF) produces clinical benefits and improves the quality of life,...
Early initiation of Empagliflozin Improves QoL in Acute HF Patients within 2 weeks: EMPULSE Trial MD Bureau9 April 2022 10:30 AM ISTIntroduction Patients hospitalized for acute heart failure (AHF) are at high risk for cardiovascular death and readmission, and also experience an...
Empagliflozin improves cognitive impairment in frail diabetics with HFpEF: Study Medha Baranwal1 April 2022 10:45 AM ISTItaly: SGLT2 inhibitor empagliflozin improves cognitive and physical impairment in frail older adults with type 2 diabetes and heart failure with...
Combo of empagliflozin plus MRA safe in HFpEF patients, may reduce hyperkalemia risk: JACC Medha Baranwal26 March 2022 10:30 AM ISTDelhi: A recent study has found that treatment with empagliflozin improves clinical outcomes in patients with heart failure with preserved ejection...
2/March/2022 Top Medical Bulletin Dr. Nandita Mohan2 March 2022 5:54 PM ISTHere are top medical stories for todayNon–Vitamin K Antagonist Oral Anticoagulants helpful in Stroke A recent study published in JAMA...
